T. Rowe Price Associates’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.78M Buy
134,993
+24,429
+22% +$551K ﹤0.01% 1684
2025
Q4
$2.62M Buy
110,564
+9,111
+9% +$222K ﹤0.01% 1638
2025
Q3
$2.53M Buy
101,453
+9,132
+10% +$197K ﹤0.01% 1633
2025
Q2
$2.12M Buy
92,321
+13,929
+18% +$323K ﹤0.01% 1609
2025
Q1
$1.76M Buy
78,392
+4,976
+7% +$116K ﹤0.01% 1664
2024
Q4
$1.44M Buy
73,416
+9,880
+16% +$196K ﹤0.01% 1799
2024
Q3
$1.16M Buy
63,536
+1,429
+2% +$27.3K ﹤0.01% 1912
2024
Q2
$1.08M Buy
62,107
+13,771
+28% +$244K ﹤0.01% 1870
2024
Q1
$947K Sell
48,336
-672,627
-93% -$14.2M ﹤0.01% 1938
2023
Q4
$16.6M Sell
720,963
-214,054
-23% -$4.79M ﹤0.01% 993
2023
Q3
$21.5M Sell
935,017
-21,164
-2% -$538K ﹤0.01% 904
2023
Q2
$25M Buy
956,181
+868,709
+993% +$22.9M ﹤0.01% 879
2023
Q1
$2.42M Buy
87,472
+10,957
+14% +$289K ﹤0.01% 1406
2022
Q4
$1.74M Buy
76,515
+2,077
+3% +$57.8K ﹤0.01% 1525
2022
Q3
$2.54M Sell
74,438
-2,705,766
-97% -$100M ﹤0.01% 1370
2022
Q2
$81M Buy
2,780,204
+1,162,270
+72% +$29.5M 0.01% 724
2022
Q1
$43.2M Buy
1,617,934
+499,816
+45% +$11.8M ﹤0.01% 1014
2021
Q4
$28.9M Buy
1,118,118
+469,625
+72% +$11.7M ﹤0.01% 1191
2021
Q3
$15.3M Sell
648,493
-2,158,846
-77% -$75.4M ﹤0.01% 1356
2021
Q2
$125M Buy
+2,807,339
New +$104M 0.01% 707

Other funds holding PRVA